Danaher initiates stock sale to help finance $20B GE Biopharma acquisition

The D.C. conglomerate aims to close the deal in the fourth quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.